DHG Pharmaceutical JSC (DHG) — Capital Reinvestment Ratio
DHG Pharmaceutical JSC (DHG) has a Capital Reinvestment Ratio of 0.03x as of December 2025, meaning it reinvests 0% of its operating cash flow (₫447.50 Billion) in capital expenditures (₫14.65 Billion). See net asset quality index of DHG Pharmaceutical JSC to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
DHG Pharmaceutical JSC Capital Reinvestment Ratio (2019–2025)
This chart tracks DHG Pharmaceutical JSC's Capital Reinvestment Ratio across 7 annual periods. Check DHG Pharmaceutical JSC total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for DHG Pharmaceutical JSC (2019–2025)
Year-by-year Capital Reinvestment Ratio for DHG Pharmaceutical JSC from 2019 to 2025. For live market cap and broader valuation context, see DHG Pharmaceutical JSC stock valuation.
| Year | Reinvestment Ratio | Operating CF (VND) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.03x | ₫1.22 Trillion | ₫42.21 Billion | ▼ -48.8% |
| 2024 | 0.07x | ₫1.32 Trillion | ₫88.70 Billion | ▼ -95.6% |
| 2023 | 1.55x | ₫279.88 Billion | ₫432.73 Billion | ▲ +495.5% |
| 2022 | 0.26x | ₫901.28 Billion | ₫233.99 Billion | ▲ +378.2% |
| 2021 | 0.05x | ₫452.44 Billion | ₫24.56 Billion | ▼ -49.5% |
| 2020 | 0.11x | ₫826.17 Billion | ₫88.81 Billion | ▲ +57.8% |
| 2019 | 0.07x | ₫838.24 Billion | ₫57.10 Billion | — |